Skip to content

Clinical trials

Dyslipidemias trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Poland Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20053
200610
20071
20082
20102
20111
20123
20132
20141
20151
20162
20172
20203
20212
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated3
Unknown status3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda10
Amgen4
Kowa Research Europe4
Novartis Pharmaceuticals4
Solvay Pharmaceuticals3
89bio, Inc.2
Eli Lilly and Company2
Medical University of Bialystok2
NewAmsterdam Pharma2
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias46
Hypercholesterolemia14
Diabetes Mellitus, Type 213
Diabetes Mellitus12
Glucose Metabolism Disorders12
Hyperlipidemias8
Lipid Metabolism Disorders6
Cardiovascular Diseases5
Metabolic Diseases5
Obesity5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.